(2-314) Evaluation on the Duration of Micafungin Use and De-escalation Following (1,3)-β-D-Glucan (BDG) Testing in Patients at an Academic Medical Center
Monday, December 5, 2022
10:45 AM – 11:45 AM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Drug Information/Drug Use Evaluation
Co-Author(s): Plamen Mangarov, Kaitlin Blotske, Sydney White, Brittny Nutt
Primary Author(s)
Omar C. Mouna
Student University of Georgia College of Pharmacy, Georgia